Indian Pharmaceutical Sector Soars: Q4 2023 Growth Trends and Insights

18 March 2024 | Monday | Report

Exclusive Report Reveals 8% Growth, Showcasing Robust Performance by Indian Pharma and MNCs Amidst Global Challenges

Indian Pharma Q4 Market Insights report

Accelerating innovation for a healthier world
View in web browser or Opt-Out

Indian Pharma Q4 Market Insights report

The IPM Q4 2023 Market Insights report features an in-depth look at how the IPM market has performed

Here are the few highlights from the report:

Market reflected growth of 8% in Q4 2023
Indian pharma companies grew at 9% while MNCs grew at 7% (PPG, Previous Period Growth) for Q4 2023
Chronic TAs (9%) outperformed Acute TAs (8%) growth

For further enquiries, please contact us.

Editor Picks

Visionary Titans: The Female Force Redefining the BioPharma Industry

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

Examining Financial Ruin, Advocating for Change, and Fostering Collaboration in Cancer Care Economics Across the Asia Pacific Region